Hepatology

  • Spur-cell anemia
    Satish Maharaj, MD, Drew Murray, MD, Simone Chang, MD and Kamila Cisak, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 649-650; DOI: https://doi.org/10.3949/ccjm.87a.20044

    A man with liver disease presents with dizziness and fatigue.

  • Miliary tuberculosis in a patient with end-stage liver disease
    Victoria Poplin, MD, Brent Harbaugh, DO, MA, Matthias Salathe, MD and Nathan C. Bahr, MD, MA
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 590-593; DOI: https://doi.org/10.3949/ccjm.87a.19143

    Chest radiography showed patchy left basilar consolidation with subtle, diffuse interstitial opacities.

  • When is contrast needed for abdominal and pelvic CT?
    Mark Radetic, MD, Robert DeVita, MD and John Haaga, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 595-598; DOI: https://doi.org/10.3949/ccjm.87a.19093

    The decision to use contrast depends on the diagnosis suspected.

  • Sickle cell disease: A primary care update
    Grace Onimoe, MD and Seth Rotz, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 19-27; DOI: https://doi.org/10.3949/ccjm.87a.18051

    Survival has improved, but patients still face multiorgan damage, chronic anemia, and debilitating pain crises.

  • Pediatric cholestatic liver disease: Successful transition of care
    Pediatric cholestatic liver disease: Successful transition of care
    Praveen Kumar Conjeevaram Selvakumar, MD, Vera Hupertz, MD, Naveen Mittal, MD, Kris V. Kowdley, MD and Naim Alkhouri, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 454-464; DOI: https://doi.org/10.3949/ccjm.86a.18140

    Many more children with liver disease are surviving into adulthood and transitioning to adult care.

  • A woman, age 35, with new-onset ascites
    William C. Lippert, MD, MPH, Eun Y. Lee, MD and Aibek E. Mirrakhimov, MD
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 257-262; DOI: https://doi.org/10.3949/ccjm.86a.17082

    She also has jaundice, hepatomegaly, and multiple abnormal laboratory results. What is the next step?

  • The tests that we order define us
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2019, 86 (3) 150; DOI: https://doi.org/10.3949/ccjm.86b.03019

    In practice we balance the inputs from Watson, “Dr. Google,” our experience, and the specific data from the patient.

  • Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
    Tavankit Singh, MD, Daniela S. Allende, MD and Arthur J. McCullough, MD
    Cleveland Clinic Journal of Medicine March 2019, 86 (3) 179-186; DOI: https://doi.org/10.3949/ccjm.86a.17118

    Biopsy is still the gold standard, but methods based on clinical information and on imaging are emerging.

  • Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Kathryn Bux Rodeman, MD and Betul Hatipoglu, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 931-937; DOI: https://doi.org/10.3949/ccjm.85a.17088

    Chief among the challenges: millions of people have diabetes.

  • Liver enzymes, August 2018
    Cleveland Clinic Journal of Medicine October 2018, 85 (10) 737;

    Agganis B, Lee D, Sepe T. Liver enzymes: No trivial elevations, even if asymptomatic. Cleve Clin J Med 2018; 85(8):612–617. doi:10.3949/ccjm.85a.17103

Pages